» Articles » PMID: 38926286

CRISPR Deletion of MiR-27 Impacts Recombinant Protein Production in CHO Cells

Overview
Specialty Molecular Biology
Date 2024 Jun 26
PMID 38926286
Authors
Affiliations
Soon will be listed here.
Abstract

MicroRNAs represent an interesting group of regulatory molecules with the unique ability of a single miRNA able to regulate the expression of potentially hundreds of target genes. In that regard, their utility has been demonstrated as a strategy to improve the cellular phenotypes important in the biomanufacturing of recombinant proteins. Common approaches to stably deplete miRNAs are the use of sponge decoy transcripts or shRNA inhibitors, both of which require the introduction and expression of extra genetic material in the cell. As an alternative, we implemented the CRISPR/Cas9 system in our laboratory to generate CHO cells which lack the expression of a specific miRNA for the purpose of functional studies. To implement the system, miR-27a/b was chosen as it has been shown to be upregulated during hypothermic conditions and therefore may be involved in influencing CHO cell growth and recombinant protein productivity. In this chapter, we present a protocol for targeting miRNAs in CHO cells using CRISPR/Cas9 and the analysis of the resulting phenotype, using miR-27 as an example. We show that it is possible to target miRNAs in CHO cells and achieved ≥80% targeting efficiency. Indel analysis and TOPO-TA cloning combined with Sanger sequencing showed a range of different indels. Furthermore, it was possible to identify clones with no detectable expression of mature miR-27b. Depletion of miR-27b led to improved viability in late stages of batch and fed-batch cultures, making it a potentially interesting target to improve bioprocess performance of CHO cells.

References
1.
Baek E, Noh S, Lee G . Anti-Apoptosis Engineering for Improved Protein Production from CHO Cells. Methods Mol Biol. 2017; 1603:71-85. DOI: 10.1007/978-1-4939-6972-2_5. View

2.
Le Fourn V, Girod P, Buceta M, Regamey A, Mermod N . CHO cell engineering to prevent polypeptide aggregation and improve therapeutic protein secretion. Metab Eng. 2013; 21:91-102. DOI: 10.1016/j.ymben.2012.12.003. View

3.
Josse L, Smales C, Tuite M . Engineering the chaperone network of CHO cells for optimal recombinant protein production and authenticity. Methods Mol Biol. 2011; 824:595-608. DOI: 10.1007/978-1-61779-433-9_32. View

4.
Toussaint C, Henry O, Durocher Y . Metabolic engineering of CHO cells to alter lactate metabolism during fed-batch cultures. J Biotechnol. 2015; 217:122-31. DOI: 10.1016/j.jbiotec.2015.11.010. View

5.
Wang Q, Yin B, Chung C, Betenbaugh M . Glycoengineering of CHO Cells to Improve Product Quality. Methods Mol Biol. 2017; 1603:25-44. DOI: 10.1007/978-1-4939-6972-2_2. View